Azar Hadadi
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 6
-
- COVID-19 Clinical Research Studies 7
- Tuberculosis Research and Epidemiology 4
- SARS-CoV-2 and COVID-19 Research 3
- Infection Control in Healthcare 3
- Co-authors
- Kasra KolahdouzanShirin AfhamiPatricia KhashayarMojgan KarbakhshNadia N. MaloufAfsaneh ShiraniFereshteh ShahcheraghiHamid Solgi
- Journals
- Scientific Reports (1 paper)Clinical Nephrology (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)Infectious Disorders - Drug Targets (1 paper)International Journal of Clinical Practice (1 paper)
- Partner nations
- IranUnited StatesAustralia
In The Last Decade
Azar Hadadi
42 papers receiving 444 citations
Peers
Comparison fields: 5 of 87
- Applied Microbiology and Biotechnology 36
- Molecular Medicine 79
- Infectious Diseases 188
- Endocrinology 27
- Emergency Medicine 47
Countries citing papers authored by Azar Hadadi
This map shows the geographic impact of Azar Hadadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azar Hadadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azar Hadadi more than expected).
Fields of papers citing papers by Azar Hadadi
This network shows the impact of papers produced by Azar Hadadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azar Hadadi. The network helps show where Azar Hadadi may publish in the future.
Co-authors
The 25 scholars most cited alongside Azar Hadadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 2 | |
| 4 | 2020 | 10 | |
| 5 | 2020 | 9 | |
| 6 | 2018 | 13 | |
| 7 | 2016 | 10 | |
| 8 | Frequency and Antimicrobial Resistance Patterns of Methicillin-Resistant Staphylococcus aureus in Tehran | 2015 | 2 |
| 9 | 2014 | 8 | |
| 10 | Solid Phase Chemical Synthesis and Structure - Activity Study of Brevinin - 2R and Analogues as Antimicrobial Peptides | 2013 | 5 |
| 11 | Frequency of qnr genes in Escherichia coli strains resistant to quinolones isolated from Ilam Imam khomani hospital and Tehran Milad hospital | 2013 | 2 |
| 12 | Determining the prevalence of methicillin- and vancomycin-resistant Staphylococcus aureus by MIC and E-Test | 2011 | 6 |
| 13 | 2011 | 3 | |
| 14 | Pulmonary Tuberculosis in Patients with HIV/AIDS in Iran | 2010 | 4 |
| 15 | 2009 | 2 | |
| 16 | 2009 | 20 | |
| 17 | INVESTIGATION OF THE FREQUENCY OF GRAM NEGATIVE NOSOCOMIAL INFECTIONS AND EVALUATION OF ANTIMICROBIAL RESISTANCE PATTERNS BY E-TEST AND DISK DIFFUSION METHODS IN SINA HOSPITAL (2004-2005) | 2008 | 2 |
| 18 | EPIDEMIOLOGICAL DETERMINANTS OF OCCUPATIONAL EXPOSURE TO HIV, HBV AND HCV IN HEALTH CARE WORKERS | 2007 | 5 |
| 19 | 2007 | 36 | |
| 20 | CLINICAL CHARACTERISTICS OF PULMONARY TUBERCULOSIS IN PATIENTS WITH HIV/AIDS: A CASE-CONTROL STUDY | 2006 | 3 |
About Azar Hadadi
Azar Hadadi is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine, Critical Care and Intensive Care Medicine and Virology, having authored 46 papers that have together received 471 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (5 papers), Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Infection Control in Healthcare (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (36 citations), Molecular Medicine (79 citations), Infectious Diseases (188 citations), Endocrinology (27 citations) and Emergency Medicine (47 citations). Azar Hadadi has collaborated with scholars based in Iran, United States and Australia. Frequent co-authors include Kasra Kolahdouzan, Shirin Afhami, Patricia Khashayar, Mojgan Karbakhsh, Nadia N. Malouf, Afsaneh Shirani, Fereshteh Shahcheraghi, Hamid Solgi, Farzad Badmasti and Marzieh Pazoki. Their work appears in journals such as Scientific Reports, Clinical Nephrology, Diagnostic Microbiology and Infectious Disease, Infectious Disorders - Drug Targets and International Journal of Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.